To date, cholinesterase inhibitors (ChE Is) are among the few approved drugs for the symptomatic treatment of AD (Figure 1) that are able to restore cortical cholinergic neurotransmission with consequent beneficial effects on cognition in both AD and PD-related dementia [9]. Here, BCHE is linked to Alzheimer disease.